Add-on Acquisition • Consumer Products

Balchem Acquires Bergstrom Nutrition

On August 30, 2022, Balchem acquired consumer products company Bergstrom Nutrition

Acquisition Context
  • This is Balchem’s 1st transaction in the Consumer Products sector.
  • This is Balchem’s 5th transaction in the United States.
  • This is Balchem’s 1st transaction in Washington.

Explore All 2386 Add-on Acquisition Consumer Products Deals - Search the Database Free


M&A Deal Summary

Date August 30, 2022
Target Bergstrom Nutrition
Sector Consumer Products
Buyer(s) Balchem
Deal Type Add-on Acquisition

Target Company

Bergstrom Nutrition

Vancouver, Washington, United States
Bergstrom Nutrition is a science-based manufacturer of methylsulfonylmethane (MSM). MSM is a widely used nutritional ingredient with strong scientific evidence supporting its benefits for joint health, sports nutrition, skin and beauty, healthy aging, and pet health. Bergstrom Nutrition is based in Vancouver, Washington.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Buyer Overview 1

Buyer

Balchem

Montvale, New Jersey, United States

Category Company
Founded 1967
Sector Chemicals
Employees1,301
Revenue 954M USD (2024)
DESCRIPTION

Balchem develops, manufactures, and sells specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, and medical sterilization industries in the United States and internationally. Balchem was founded in 1967 and is based in Montvale, New Jersey.


Deal Context for Buyer #
Overall 7 of 7
Sector: Consumer Products 1 of 1
Type: Add-on Acquisition 7 of 7
State: Washington 1 of 1
Country: United States 5 of 5
Year: 2022 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-14 Kappa Bioscience

Oslo, Norway

Kappa Bioscience is a science-based manufacturer of specialty vitamin K2 for the human nutrition industry. The company's discoveries include: The synthesis of pure, all-bioactive vitamin K2 MK-7, an essential vitamin needed to direct calcium around our bodies and keep hearts, bones, and lots of other things healthy. Today, that pioneering spirit is still as strong as ever. With patented processes, innovative technology, and renowned expertise, Kappa Bioscience AS produces K2VITAL and K2VITAL Delta; vitamin K2 with unmatched purity and stability, in a wider range of formulations than anyone else, to bring the best possible benefits of vitamin K2 to everyone. From vitamin K2 and turn-key solutions to research and marketing initiatives, to product launches and growth strategies, Kappa Bioscience AS believes in doing it right. That means developing products and services that set new standards of excellence, made with integrity, and through close collaboration. Kappa Bioscience was formed in 2006 and is based in Hamburg, Germany.

Buy -